Persistent unilocular ovarian cysts in a general population of postmenopausal women: Is there a place for expectant management?

Obstetrics and Gynecology

Volumn 102, Issue 3, 2003, Pages 589-593

  Nardo, Luciano G ^a,b   Kroon, Nicolette D ^a   Reginald, Philip W ^a  

^a WEXHAM PARK HOSPITAL   (United Kingdom)

^b 1 Broome Lodge ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; BIOLOGICAL MARKER;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; BLEEDING; CANCER SURGERY; CYSTADENOCARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OVARY CYST; PELVIS; PHYSICAL EXAMINATION; POPULATION; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME; CHRONIC DISEASE; COHORT ANALYSIS; HOSPITALIZATION; MENOPAUSE; METHODOLOGY; MIDDLE AGED; MONITORING; PROGNOSIS; RADIOIMMUNOASSAY; TIME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OVARIAN CYSTS; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0141921342     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00663-X     Document Type: Article

References (30)

1. Levine D., Gosink B.B., Wolf S.I., Feldesmann M.R., Pretorius D.H. Simple adnexal cysts The natural history in postmenopausal women . Radiology. 184:1992;653-659.
2. Bailey C.L., Ueland F.R., Land G.L., DePriest P.D., Gallion H.H., Kryscio R.J., et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 69:1998;3-7.
3. Ekerhovd E., Wienerroith H., Staudach A., Granberg S. Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography A comparison between ultrasonographic morphologic imaging and histopathologic diagnosis . Am J Obstet Gynecol. 184:2001;48-54.
4. Crayford T.J.B., Campbell S., Bourne T.H., Rawson H.J., Collins W.P. Benign ovarian cysts and ovarian cancer A cohort study with implications for screening . Lancet. 355:2000;1060-1063.
5. Tanos V., Schenker J.G. Ovarian cysts A clinical dilemma . Gynecol Endocrinol. 8:1994;59-67.
6. Cancer incidence in Sweden. Annual report 1996. Stockholm, Sweden: Swedish Cancer Registry, Centre for Epidemiology, National Board of Health and Welfare, 1996.
7. Young R.C., Walton L.A., Ellenberg S.S., Homesley H.D., Wilbanks G.D., Decker D.G., et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med. 322:1990;1021-1027.
8. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1996. Cancer J Clin. 65:1996;5-27.
9. Bell R., Petticrew M., Sheldon T. Performance of screening tests for ovarian cancer Results of a systematic review . Br J Obstet Gynaecol. 105:1998;1136-1147.
10. Granberg S., Wikland M., Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis Criteria to be used for ultrasound evaluation . Gynecol Oncol. 35:1989;139-144.
11. Osmers R.G., Osmers M., von Maydell B., Wagner B., Kuhn W. Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography. Am J Obstet Gynecol. 175:1996;428-434.
12. Pascual M.A., Hereter L., Tresserra F., Carreras O., Ubeda A., Dexeus S. Transvaginal sonographic appearance of functional ovarian cysts. Hum Reprod. 12:1997;1246-1249.
13. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999. Cancer J Clin. 49:1999;8-31.
14. Bourne T., Campbell S., Steer C., Whitehead M.I., Collins W.P. Transvaginal colour flow imaging A possible new screening technique for ovarian cancer . BMJ. 299:1989;1367-1370.
15. Vuento M.H., Pirhonen J.P., Makinen J.I., Laippala P.J., Gronroos M., Salmi T.A. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound. Cancer. 76:1995;1214-1218.
16. Jacobs I.J., Skates S., Davies A.P., Woolas R.P., Jeyerajah A., Weidemann P., et al. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration A prospective cohort study . BMJ. 313:1996;1355-1358.
17. Eagle K., Ledermann J.A. Tumor markers in ovarian malignancies. Oncologist. 2:1997;324-329.
18. Fures R., Bukovic D., Hodek B., Klaric B., Herman R., Grubisic G. Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage. Coll Antropol. 23:1999;189-194.
19. Jeyarajah A.R., Ind T.E.J., MacDonald N., Skates S., Oram D.H., Jacobs I.J. Increased mortality in post-menopausal women with serum CA125 elevation. Gynecol Oncol. 73:1999;242-246.
20. Pauler D.K., Menon U., McIntosh M., Symecko H.L., Skates S.J., Jacobs I.J. Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 10:2001;489-493.
21. Jacobs I., Davies A.P., Bridges J., Stabile I., Fay T., Lower A., et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 306:1993;1030-1034.
22. Menon U., Talaat A., Jeyarajah A.R., Rosenthal A.N., MacDonald N.D., Skates S.J., et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer. 80:1999;1644-1647.
23. Kurjak A., Kupesic S., Simunic V. Ultrasonic assessment of the peri- and postmenopausal ovary. Maturitas. 41:2002;245-254.
24. Conway C., Zalud I., Dilena M., Maulik D., Schulman H., Haley J., et al. Simple cyst in the postmenopausal patient Detection and management . J Ultrasound Med. 17:1998;369-372.
25. Collins W.P., Bourne T.H., Campbell S. Screening strategies for ovarian cancer. Curr Opin Obstet Gynecol. 10:1998;33-39.
26. Niloff J.M., Klug T.L., Schaetzl E., Zurawski V.R., Knapp R.C., Bast R.C. Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol. 148:1984;1057-1058.
27. Penna L., Manyonda I., Amias A. Intra-abdominal miliary tuberculosis presenting as disseminated ovarian carcinoma with ascites and raised CA 125. Br J Obstet Gynaecol. 100:1993;1051-1053.
28. Rustin G.J., Nelstrop A.E., Mclean P., Brady M.F., McGuire W.P., Hoskins W.J., et al. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol. 14:1996;1545-1551.
29. Ind T.E.J., Iles R., Shepherd J.H., Chard T. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer. Br J Obstet Gynaecol. 104:1997;1024-1029.
30. Goldstein S.R., Subramanyam B., Snyder J.R., Beller U., Raghavendra B.N., Beckman E.M. The postmenopausal cystic adnexal mass The potential role of ultrasound in conservative management . Obstet Gynecol. 73:1989;8-10.